
- Pharmaceutical Technology-09-02-2020
 - Volume 44
 - Issue 9
 
Pressure Transmitter for Single-Use Applications
The Rosemount 550PT Pressure Transmitter from Emerson is designed for single-use bioprocessing applications to enhance processes while preserving product integrity.
The Rosemount 550PT Pressure Transmitter from Emerson is designed for single-use bioprocessing applications to enhance processes while preserving product integrity.
Installed with a disposable Rosemount 551 Single-Use Process Connector, the device integrates a flexible isolating diaphragm that provides a sterile barrier that keeps the pressure instrument’s sensor separate from the process media, eliminating contamination risks and making the device reusable.
The device is compact for single-use applications and comes equipped with a transmitter that generates a standard 4-20mA signal output. The pressure sensor offers +/- 0.15 psi accuracy, and after being clamped to the process connector, the transmitter can be zeroed in place for batch-to-batch repeatability and long-term stability.
The device also comes equipped with a sensor and matching process connector combination, which can be included in several applications and can withstand 75 psi with the instrument installed and 7.5 psi without an instrument installed.
Articles in this issue
about 4 years ago
Moving Forward in Serializationabout 5 years ago
Preparing Pandemic Vaccine Capacityabout 5 years ago
Tracking API Quality During a Pandemicabout 5 years ago
Capsule Innovations: Speeding Up Drug Developmentabout 5 years ago
Manufacturing Drug–Device Combination Productsabout 5 years ago
Advancing Understanding of a Traditional Techniqueabout 5 years ago
Pharmacovigilance Under Scrutiny: Why Companies are Falling Shortabout 5 years ago
Pharmacopoeia Compliance: A Practical Guideabout 5 years ago
Streamlining Method Transfer Across Global SitesNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.





